WHO-GMP Certified Commercial Pack · Product Code: AKP-026
Mometasone Cream 0.1%
Formulation Overview: Once-daily medium-to-high potency non-fluorinated corticosteroid cream with favorable local-to-systemic risk ratio for sensitive inflammatory eczema and allergic dermatitis. Formulated with Mometasone Furoate IP / USP 0.1% w/w (0.1% w/w) in Topical Cream dosage form under Dermatology & Topicals, manufactured to IP / BP / USP Compendial standards and supplied in 15g / 30g Collapsible Lami / Aluminum Tube with Carton with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-026 |
|---|---|
| Therapeutic Sector | Dermatology & Topicals |
| Dosage Form | Topical Cream |
| Active Ingredient | Mometasone Furoate IP / USP 0.1% w/w |
| Strength / Purity | 0.1% w/w |
| Clinical Indication | Atopic dermatitis, contact dermatitis, seborrheic dermatitis, and pruritic dermatoses |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 15g / 30g Collapsible Lami / Aluminum Tube with Carton |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; do not freeze |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |